A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
Researchers from Nantong University developed a novel targeted drug delivery system using functionalized pillararenes for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results